Dr Fei Sim’s vision for scope of practice
PSA's National President Dr Fei Sim FPS discusses the enormous changes that could come out of the scope of practice review.
Take Home Naloxone is becoming embedded in pharmacy practice
This International Overdose Awareness Day, pharmacists share how the Take Home Naloxone Program is helping to save patients’ lives.
Achieving gender equity in the pharmacy profession
To mark International Women’s Day on 8 March, two pharmacists discuss their careers and the biases that must be broken to ensure women can succeed.
Limited evidence for medicinal cannabis in most mental health conditions
A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.
How you can help advocate for better pharmacist remuneration
On top of a harrowing few years working through the pandemic, it’s time pharmacists were fairly remunerated for their time and expertise. PSA needs your help to get the message across.
Chlorpromazine: from antihistamine to antipsychotic
While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.













